Home

The Korea Herald

Most Popular

  1. 1

    Can Korea break away from apartment fixation?

    Can Korea break away from apartment fixation?
  2. 2

    Assembly clash looms as opposition pushes vote on W4tr budget cut

    Assembly clash looms as opposition pushes vote on W4tr budget cut
  3. 3

    BTS members dominate charts, award shows despite military service

    BTS members dominate charts, award shows despite military service
  4. 4

    Nearly 10,000 elementary school staff suffer from depression: data

    Nearly 10,000 elementary school staff suffer from depression: data
  5. 5

    Which surname will Moon and Jung give their child?

    Which surname will Moon and Jung give their child?
  6. 6

    Inside Korea’s diplomatic failure at Japan’s memorial ceremony

    Inside Korea’s diplomatic failure at Japan’s memorial ceremony
  7. 7

    Hyundai-Kia may face 19% profit loss from US tariffs: report

    Hyundai-Kia may face 19% profit loss from US tariffs: report
  8. 8

    Can government be cool? South Korea's local officials think so

    Can government be cool? South Korea's local officials think so
  9. 9

    (G)I-dle confirms full-unit contract renewal at MMA

    (G)I-dle confirms full-unit contract renewal at MMA
  10. 10

    [Herald Interview] Director of 'Jeongnyeon: The Star is Born' discusses bringing together viewers across ages, genders

    [Herald Interview] Director of 'Jeongnyeon: The Star is Born' discusses bringing together viewers across ages, genders
소아쌤

Endometriosis drug Visanne to be listed on the PBS, more than halving its annual cost

By ABC NEWS (Australia)

Published : Dec. 2, 2024 - 08:02

    • Link copied


Visanne, also known by the generic name ‘dienogest’, will be listed on the PBS, making it the first endometriosis treatment in 30 years to be subsidised by the federal government. The annual cost of a course of daily tablets will be slashed from more than $800 to $380, or around $90 for pension and concession card holders.

More from Headlines